Here, on the above-introduced scientific basis, we investigated whether IFN-I mediates changes in PKM2 oligomeric state and its downstream functions, impacts white adipocytes’ inflammatory cytokine production, and contributes to metabolic disease severity in obesity. Here, PKM is linked to metabolic disease.